Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ARAI vs MYSE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ARAI Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 3–3 Matrix Metrics)
ARAI Overall Winner
6-Pillar Tally: ARAI 4 – 1 MYSE (1 Tie)
Matrix Metrics: ARAI 3 – 3 MYSE
As of Nov 20, 2026, Arrive AI Inc. (ARAI) is the stronger overall head-to-head candidate over Myseum, Inc. (MYSE) in the Tradestie Institutional Equity Comparison Engine, winning 3–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARAI carries a Unified Composite Score of 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin), whereas MYSE carries 35.8/100 (SELL) at $0.81 (N/M Forward P/E, -3371223.4% operating margin).
- Composite vs. Pillar Nuance: While MYSE currently prints a higher short-term Unified Composite Score (35.8/100 SELL vs. ARAI 34.4/100 SELL), ARAI captures the overall institutional head-to-head verdict (3–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-18105.8% vs. -3371223.4% operating margin) and revenue trajectory (+432.9% vs. -89.6% YoY).
- Defensive Composite Rating Caution: Although ARAI compares more favorably head-to-head, both ARAI (34.4/100 SELL) and MYSE (35.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
- Technical & Structure Timing Caution: ARAI trades in a Markup technical trend (SURGE options phase, RSI 58.1); meanwhile MYSE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About ARAI vs MYSE
ARAI
Head-to-Head Winner
Arrive AI Inc. Common Stock
$1.21
-21.94% 1D
Market Cap
$2.2M
TTM Revenue
$84,400
Forward P/E
N/M
Beta / 30D Vol
-4.44β · 11485% Vol
Unified Composite Score
34.4
SELL
Tech 50.0
Fund 32.0
Flow 50.0
Mom 58.9
Weinstein Technical Phase
Markup · Hold / add on dips
MYSE
Myseum, Inc. Common Stock
$0.81
-4.67% 1D
Market Cap
$4.4M
TTM Revenue
$205
Forward P/E
N/M
Beta / 30D Vol
1.13β · 81% Vol
Unified Composite Score
35.8
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (ARAI 4 – 1 MYSE)
1. Valuation Multiples
ARAI
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
55.5x
N/M
2. Growth & Scale
ARAI
Revenue Growth (YoY)
+432.9%
-89.6%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$84,400
$205
Market Cap
$2.2M
$4.4M
3. Profitability & Quality
ARAI
Gross Margin
100.0%
N/A
Operating Margin
-18105.8%
-3371223.4%
Net Profit Margin
0.0%
0.0%
Return on Equity (ROE)
-840.7%
-224.2%
4. Balance Sheet & Cash Flow
MYSE
Cash Generation (TTM)
-$15M EBITDA
-$4.5M
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
$2.5M Net Debt (1.15x D/E)
-$569,907 Net Debt (0.05x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ARAI
Options Structure Phase
SURGE
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
ACCUMULATION · Markup
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Scientific & Technical Instruments Operator
Software - Application Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ARAI (3) vs MYSE (3)| Institutional Metric | ARAI | MYSE | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $2.2M | $4.4M | Tie | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | +432.9% | -89.6% | ARAI | |
| Operating Margin (TTM) | -18105.8% | -3371223.4% | ARAI | |
| Net Profit Margin | 0.0% | 0.0% | Tie | |
| Return on Equity (ROE) | -840.7% | -224.2% | MYSE | |
| 52-Week Range Position | 28% ($0–$4) | 0% ($1–$6) | ARAI | |
| Beta / 30D Volatility | -4.44β · 11485% Vol | 1.13β · 81% Vol | MYSE | |
| Unified Institutional Score | 34.4 / 100 (SELL) | 35.8 / 100 (SELL) | MYSE | |
| Trailing 12M Revenue (USD) | $84,400 | $205 | Scale | |
| Gross Profit Margin (TTM) | 100.0% | N/A | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 55.5x EV/Rev | N/M PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$15M EBITDA ($2.5M Net Debt (1.15x D/E)) | -$4.5M (-$569,907 Net Debt (0.05x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ARAI +896.12 pp
3M Horizon
ARAI +493.66 pp
6M Horizon
ARAI +141.11 pp
1Y Horizon
MYSE +12.57 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ARAI Revenue | MYSE Revenue | ARAI Op. Margin | MYSE Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2021 | N/A | $0M | N/A | -243836.9% | MYSE |
| FY2022 | N/A | $0M | N/A | -26456.8% | MYSE |
| FY2023 | N/A | $0M | N/A | -1307147.5% | MYSE |
| FY2024 | N/A | $0M | N/A | -737882.3% | MYSE |
| FY2025 | $0M | $0M | -11325.7% | -998192.4% | ARAI |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
ARAI
SURGE
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
ACCUMULATION
Exact ARAI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
MYSE
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact MYSE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
ARAI Moat Profile
Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
MYSE Moat Profile
Cyclical / Execution-Driven Positioning
Software - Application Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ ARAI vs MYSE Key Questions & Quantitative Answers
As of Nov 20, 2026, Arrive AI Inc. (ARAI) is the stronger overall head-to-head candidate over Myseum, Inc. (MYSE) in the Tradestie Institutional Equity Comparison Engine, winning 3–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARAI carries a Unified Composite Score of 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin), whereas MYSE carries 35.8/100 (SELL) at $0.81 (N/M Forward P/E, -3371223.4% operating margin). Composite vs. Pillar Nuance: While MYSE currently prints a higher short-term Unified Composite Score (35.8/100 SELL vs. ARAI 34.4/100 SELL), ARAI captures the overall institutional head-to-head verdict (3–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-18105.8% vs. -3371223.4% operating margin) and revenue trajectory (+432.9% vs. -89.6% YoY). Defensive Composite Rating Caution: Although ARAI compares more favorably head-to-head, both ARAI (34.4/100 SELL) and MYSE (35.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: ARAI trades in a Markup technical trend (SURGE options phase, RSI 58.1); meanwhile MYSE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ARAI leads the Growth & Scale pillar: ARAI posts +432.9% YoY revenue growth and +0.0% YoY earnings growth on $84,400 TTM revenue (100.0% gross margin, -18105.8% operating margin), compared with MYSE at -89.6% YoY revenue growth and +0.0% YoY earnings growth on $205 TTM revenue (N/A gross margin, -3371223.4% operating margin). Across the 5-period historical trajectory (FY2021 to FY2025), ARAI cumulative revenue shifted N/A while MYSE shifted N/A. In operating R&D and SG&A reinvestment, ARAI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MYSE.
ARAI screens cheaper on headline valuation multiples. ARAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 55.5x EV/Revenue (unreported EBITDA margin), whereas MYSE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARAI (-840.7% ROE) versus MYSE (-224.2% ROE) capital efficiency.
In options market volatility and institutional positioning, ARAI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (-4.44β · 11485% Vol realized risk). By comparison, MYSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.13β · 81% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
MYSE vs ARAI · Reverse Pair
ARAI vs BNAI
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal